TD Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,700
| Closed | -$433K | – | 1427 |
|
|
2023
Q1 | $433K | Hold |
10,700
| – | – | ﹤0.01% | 1290 |
|
|
2022
Q4 | $498K | Hold |
10,700
| – | – | ﹤0.01% | 1285 |
|
|
2022
Q3 | $561K | Buy |
10,700
+500
| +5% | +$26.2K | ﹤0.01% | 1276 |
|
|
2022
Q2 | $482K | Sell |
10,200
-3,100
| -23% | -$146K | ﹤0.01% | 1298 |
|
|
2022
Q1 | $947K | Sell |
13,300
-12,200
| -48% | -$869K | ﹤0.01% | 1244 |
|
|
2021
Q4 | $1.91M | Buy |
25,500
+6,500
| +34% | +$486K | ﹤0.01% | 1144 |
|
|
2021
Q3 | $1.08M | Buy |
+19,000
| New | +$1.08M | ﹤0.01% | 1232 |
|
|
2021
Q2 | – | Sell |
-17,847
| Closed | -$880K | – | 1535 |
|
|
2021
Q1 | $880K | Sell |
17,847
-5,300
| -23% | -$261K | ﹤0.01% | 1285 |
|
|
2020
Q4 | $974K | Hold |
23,147
| – | – | ﹤0.01% | 1192 |
|
|
2020
Q3 | $1.06M | Sell |
23,147
-6,100
| -21% | -$279K | ﹤0.01% | 1074 |
|
|
2020
Q2 | $1.47M | Buy |
29,247
+800
| +3% | +$40.2K | ﹤0.01% | 951 |
|
|
2020
Q1 | $1.46M | Sell |
28,447
-4,600
| -14% | -$237K | ﹤0.01% | 901 |
|
|
2019
Q4 | $2.04M | Sell |
33,047
-3,300
| -9% | -$204K | ﹤0.01% | 922 |
|
|
2019
Q3 | $2.18M | Sell |
36,347
-2,201
| -6% | -$132K | ﹤0.01% | 892 |
|
|
2019
Q2 | $3.25M | Buy |
38,548
+3,400
| +10% | +$287K | ﹤0.01% | 798 |
|
|
2019
Q1 | $3.36M | Buy |
35,148
+3,331
| +10% | +$318K | 0.01% | 789 |
|
|
2018
Q4 | $2.25M | Buy |
31,817
+145
| +0.5% | +$10.3K | ﹤0.01% | 887 |
|
|
2018
Q3 | $2.71M | Sell |
31,672
-9,089
| -22% | -$777K | ﹤0.01% | 920 |
|
|
2018
Q2 | $4.72M | Buy |
40,761
+27,319
| +203% | +$3.17M | 0.01% | 719 |
|
|
2018
Q1 | $1.09M | Buy |
13,442
+308
| +2% | +$24.9K | ﹤0.01% | 1041 |
|
|
2017
Q4 | $771K | Buy |
+13,134
| New | +$771K | ﹤0.01% | 1108 |
|